Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26498. Epub 2017 Feb 14.
The above article, published online 23 August 2013 in Pediatric Blood and Cancer, Volume 60, Issue 12, December 2013, Pages 2060-2067, has been retracted by agreement among the authors, the journal's Editor-in-Chief, Peter E. Newburger, M.D., and Wiley Periodicals, Inc. The decision to retract was agreed upon following notification that the paper substantially duplicates a prior study already published in Chinese https://www.ncbi.nlm.nih.gov/pubmed/23611221. The authors were not aware that publication in another language would constitute a duplicate publication and, upon being informed of this fact, have agreed to withdraw the paper from Pediatric Blood and Cancer. Reference Li X, Li D, Zhuang Y, Shi Q, Wei W and Ju X. Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL. Pediatr Blood Cancer. 2013; 60: 2060-2067. doi:10.1002/pbc.24583.
上述文章于2013年8月23日在线发表于《儿科血液与肿瘤学》，2013年12月第60卷第12期，第2060 - 2067页，经作者、该期刊主编彼得·E·纽伯格医学博士以及威利期刊公司协商一致后予以撤回。在得知该论文与此前已发表于中文文献（https://www.ncbi.nlm.nih.gov/pubmed/23611221）的一项研究存在实质性重复后，决定予以撤回。作者当时并未意识到以另一种语言发表会构成重复发表，在得知这一情况后，已同意从《儿科血液与肿瘤学》撤回该论文。参考文献：Li X, Li D, Zhuang Y, Shi Q, Wei W和Ju X。儿童常见前体B细胞急性淋巴细胞白血病中miR - 708及其靶标的过表达。《儿科血液与肿瘤学》。2013年；60: 2060 - 2067。doi:10.1002/pbc.24583 。
